CMV is a viral infection that can have devastating effects on unborn babies. Do you educate your obstetric patients about CMV prevention?
Cytomegalovirus (CMV) infection is the least known but most common viral cause of permanent disabilities in newborns. Although most CMV infections are harmless, CMV can cause disease in unborn babies and in those with weakened immune systems. Despite this, less than 50% of obstetricians counsel their patients about the dangers of CMV, and 80% of women are unaware of CMV.
CMV is spread from one person to another, usually by close and prolonged contact with body fluids, including urine and saliva. CMV is very prevalent among healthy children 1 to 3 years of age who attend childcare. Pregnant mothers of toddlers who attend childcare and those who work closely with these children, are at the greatest risk for infection. According to the CDC, nearly 1 out of every 150 babies (roughly 30,000 children annually) is born with a congenital CMV infection. About 1 out of every 750 babies (more than 5,000 children annually) suffers permanent disability as a result.
“CMV is the most common virus most people have never heard of,” said Gail Demmler-Harrison, MD, infectious disease specialist and CMV researcher at Texas Children’s Hospital, who is also associated with Maddie's Mission, a local nonprofit group raising awareness and funding for CMV research. “Most of the time, when a baby is diagnosed with CMV, mothers haven’t heard of it, but it’s a virus that every woman needs to know about.”
Do you educate all your obstetric patients about the dangers of CMV infection?
S1E4: Dr. Kristina Adams-Waldorf: Pandemics, pathogens and perseverance
July 16th 2020This episode of Pap Talk by Contemporary OB/GYN features an interview with Dr. Kristina Adams-Waldorf, Professor in the Department of Obstetrics and Gynecology and Adjunct Professor in Global Health at the University of Washington (UW) School of Medicine in Seattle.
Listen
Similar delivery times between misoprostol dosages among obese patients reported
May 29th 2024A recent study found that obese patients undergoing induction of labor experienced similar delivery times regardless of whether they received 50 μg or 25 μg of vaginal misoprostol, though multiparous patients showed faster delivery with the higher dosage.
Read More